|
Catalog Number SEPX-8-6-40-135 |
Device Problems
Difficult to Remove (1528); Activation, Positioning or Separation Problem (2906)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/23/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
A physician was implanted a protégé rx self expanding stent for the treatment of a plaque lesion with 80% stenosis in the proximal region of the common carotid artery.There was moderate tortuosity and calcification.A spider device was used for embolic protection.The device was prepped as per the ifu with no issues identified.There was no resistance encountered when advancing the device and no excessive force used.It was reported the patient had internal carotid artery stenosis, and a protégé stent was placed.When it was deployed in the body, the handle was fixed, and when the catheter was withdrawn, the catheter could not be withdrawn and deployed.No difficulties removing the device and delivery system.It was replaced with the stent of the same model to complete the operation.There was no patient injury.
|
|
Manufacturer Narrative
|
Product analysis the device was received with the touhy-borst tight.The device was returned with the stent fully enclosed, (photo 5) and confirmed as 30mm the device was flushed and would only flush from the y connector port, unable to flush from the guidewire port a 0.014¿ guidewire was loaded but could not pass through the kinked inner, it met with resistance.The guidewire was removed and measured against the device.A kinked inner lumen was observed near the guidewire port, distally measured at approx.18.5cm the device was loaded into the deployment fixture, the stent deployed at 0.95lb and the stent confirmed as 40mm.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|